Scholl athlete's foot powder

  • image

Scholl athlete's foot powder Medicine

Top 20 drugs with the same components:

Dertec Absorbine athlete's foot Absorbine athletes foot Absorbine jr cream Absorbine jr. antifungal Absorbine jr. antifungal (topical) Aftate Blis-to-sol Blis-to-sol (tolnaftate) Clarus antifungal Dermasept antifungal Examples include absorbine jr Fungi-guard Lamisil af defense Lamisil defense Mycocide ns Podactin (tolnaftate) Q-naftate Q-naftate (topical) Tinactin

Overdose

Not relevant to topical use.

Shelf life

24 months, unopened

Once opened, use within 6 months

Contraindications

Not recommended for nail or scalp infections.

Incompatibilities

None stated.

List of excipients

Talc

Starch

Pharmaceutical form

Powder for topical application

Undesirable effects

Adverse reactions have been ranked under headings of frequency using the following convention:

Very common

> 1/10

Common

> 1/100 to > 1/10

Uncommon

> 1/1,000 to < 1/100

Rare

> 1/10,000 to < 1/1,000

Very rare

<1/10,000

Within easy frequency grouping, undesirable effects are presented in order of decreasing seriousness.

System Organ Class

Frequency

Skin and subcutaneous tissue disorder

Unknown

Skin reactions

Skin irritation

Pruritis

Contact dermatitis

Preclinical safety data

None stated

Therapeutic indications

For the prevention and treatment of Athlete's Foot.

Pharmacodynamic properties

Tolnaftate

Topical antifungal agent (ATC Classification: D01AE 18)

Pharmacokinetic properties

Not applicable for a topical dosage form of this type

Date of revision of the text

19/09/2016

Name of the medicinal product

Scholl Athletes Foot Powder

Superdrug Athletes Foot Powder

Marketing authorisation holder

Scholl Consumer Products Ltd

103-105 Bath Road

Slough

SL1 3UH

UK

Special precautions for storage

Store below 25°C.

Nature and contents of container

High density poly-ethylene container with sifter assembly. 75g of product

Marketing authorisation number(s)

PL 00587/0007

Qualitative and quantitative composition

Tolnaftate 1.0%w/w

Special warnings and precautions for use

For external use only

Keep out of eyes

If symptoms do not improve within 10 days, discontinue use and consult your doctor

Keep out of the reach and sight of children

Effects on ability to drive and use machines

None stated.

Dosage (Posology) and method of administration

Wash and dry infected area, and apply twice daily or as directed by your doctor. Dust feet liberally, especially between toes. For added protection dust on socks, hosiery and inside shoes. Continue treatment for two weeks after symptoms disappear.

Special precautions for disposal and other handling

No special precautions required

Date of first authorisation/renewal of the authorisation

24/04/1985 / 12/01/2005